Reduction of the influenza burden in children

被引:39
作者
Rennels, MB [1 ]
Meissner, HC [1 ]
机构
[1] Comm Infect Dis, Elk Grove Village, IL 60007 USA
关键词
influenza; vaccine; treatment; diagnosis; antiviral;
D O I
10.1542/peds.110.6.e80
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Epidemiologic studies have shown that children of all ages with certain chronic conditions, such as asthma, and otherwise healthy children younger than 24 months (6 through 23 months) are hospitalized for influenza and its complications at high rates similar to those experienced by the elderly. Annual influenza immunization is already recommended for all children 6 months and older with high-risk conditions. By contrast, influenza immunization has not been recommended for healthy young children. To protect children against the complications of influenza, increased efforts are needed to identify and recall high-risk children. In addition, immunization of children between 6 through 23 months of age and their close contacts is now encouraged to the extent feasible. Children younger than 6 months may be protected by immunization of their household contacts and out-of-home caregivers. The ultimate goal is universal immunization of children 6 to 24 months of age. Issues that need to be addressed before institution of routine immunization of healthy young children include education of physicians and parents about the morbidity caused by influenza, adequate vaccine supply, and appropriate reimbursement of practitioners for influenza immunization. This report contains a summary of the influenza virus, protective immunity, disease burden in children, diagnosis, vaccines, and antiviral agents.
引用
收藏
页数:18
相关论文
共 131 条
[1]   VIRUS-INDUCED NEUTROPHIL DYSFUNCTION - ROLE IN THE PATHOGENESIS OF BACTERIAL-INFECTIONS [J].
ABRAMSON, JS ;
WHEELER, JG .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) :643-652
[2]   INFLUENZA-A VIRUS-INDUCED POLYMORPHONUCLEAR LEUKOCYTE DYSFUNCTION IN THE PATHOGENESIS OF EXPERIMENTAL PNEUMOCOCCAL OTITIS-MEDIA [J].
ABRAMSON, JS ;
GIEBINK, GS ;
QUIE, PG .
INFECTION AND IMMUNITY, 1982, 36 (01) :289-296
[3]  
[Anonymous], 1999, MMWR, V48, DOI [DOI 10.1037/E547822006-001, 10.1037/e547822006-001]
[4]   IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT-POPULATION [J].
BARKER, WH ;
MULLOOLY, JP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1980, 112 (06) :798-813
[5]   Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Mehta, HB ;
Mahmood, K ;
Reisinger, K ;
Treanor, J ;
Zangwill, Z ;
Hayden, FG ;
Bernstein, DI ;
Kotloff, K ;
King, J ;
Piedra, PA ;
Block, SL ;
Yan, LH ;
Wolff, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :1133-1137
[7]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[8]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[9]   LIVE ATTENUATED INFLUENZA-A VIRUS-VACCINES IN CHILDREN - RESULTS OF A FIELD TRIAL [J].
BELSHE, RB ;
VANVORIS, LP ;
BARTRAM, J ;
CROOKSHANKS, FK .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (06) :834-840
[10]  
BERNSTEIN DI, 1982, PEDIATRICS, V69, P404